Last reviewed · How we verify
NCT06131671
Whole-body Electrostimulation on Functional Mobility and Quality of Life in the Elderly
NA trial testing Whole-body electrical stimulation in Aged in 30 participants. Completed in 15 April 2024.
22 March 2024
Quick facts
| Lead sponsor | Federal University of Health Science of Porto Alegre |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 22 January 2024 |
| Primary completion | 22 March 2024 |
| Estimated completion | 15 April 2024 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Whole-body electrical stimulation
Conditions studied
- Aged — all drugs for Aged →
Sponsor
Federal University of Health Science of Porto Alegre
Who can join
Adults 60 to 85, any sex, with Aged. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Elderly people experience reduced strength, mass and muscle function throughout the aging process, and this negatively affects the functionality and quality of life of these individuals. A randomized clinical trial will be carried out with 30 volunteers who will be allocated into two groups (whole-body electrical stimulation or control). Whole-body electrical stimulation (WBS) sessions will take place twice a week, for 8 weeks, totaling 16 sessions. The primary outcomes of this study are functional mobility (Timed Up and Go test) and quality of life (EQ-5D questionnaire). Functional mobility will be assessed at baseline, after 4 and 8 weeks of treatment or follow-up. Quality of life will be assessed only at the beginning and end of 8 weeks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06131671
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Whole-body electrical stimulation
Trials testing the same drug.
- NCT06761963 — Chronic Effect of Whole-body Electrical Stimulation in COPD Patients · NA · not yet recruiting
- NCT06502522 — Effects of Whole-body Electrostimulation on Patients With Chronic Kidney Disease · NA · not yet recruiting
- NCT05885152 — Acute Effect of Whole-body Electrical Stimulation in COPD Patients · NA · completed
Other recruiting trials for Aged
Currently open trials in the same condition.
- NCT07481851 — Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients · recruiting
- NCT07358338 — Application of Device-based Training to Improve Postural Control in Older Adults With CCI · NA · active not recruiting
- NCT06901167 — Evaluation of a Residential In-Reach Program in Regional and Rural Australia · NA · recruiting
- NCT06973460 — Robotic-Assisted System in Enhancing Balance, Postural Stability, Functional Gait and Fall Efficacy in Older Adults · NA · recruiting
- NCT06929351 — Effect of Otago Exercise Program in Comparison With Dual Task Training on Balance and Postural Control in Elderly Popula · NA · active not recruiting
Other Federal University of Health Science of Porto Alegre trials
Trials by the same sponsor.
- NCT07432113 — Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syn · NA · not yet recruiting
- NCT07232862 — Analysis Of The Effect Of A Fine Manual Skills Intervention In A Specific Context On The Linguistic Processing of Health · NA · recruiting
- NCT07172698 — Effects of a Multicomponent Protocol With Emphasis on Muscle Power Training on Bradykinesia in Individuals With Parkinso · NA · completed
- NCT06761963 — Chronic Effect of Whole-body Electrical Stimulation in COPD Patients · NA · not yet recruiting
- NCT05814432 — Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06131671 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal University of Health Science of Porto Alegre
- Last refreshed: 6 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06131671.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing